While our study focused on KRAS-mutant lung cancers treated with KRAS or MEK inhibitor targeted therapies, we also provide evidence that LKB1 suppresses JNK activation in response to UV radiation, suggesting a fundamental role for LKB1 in regulating JNK stress signaling in response to a variety of stimuli. Here, MAP2K7 is linked to lung carcinoma.